RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Decheng Capital
D

Decheng Capital portfolio

Decheng Capital has 11 portfolio companies on record at Recent Funding, with 6 investments in the last 12 months.

Website: decheng.com.
Type: Venture capital.
Portfolio on Recent Funding: 11.
Deals, last 12 months: 6.
Rounds led: 6 of 13.
Capital in their rounds: $792M.
Latest deal: Phrontline Biopharma · Nov 12, 2026.
About this page

It is a venture capital firm based in Silicon Valley, US, founded in 2012. It led 6 of the 13 rounds it joined. Its most recent investment on record is Phrontline Biopharma's $40M Series A round in November 2026, which it led, alongside Songqing Capital, Xiamen C&D Corporation, Oriza Holdings and 3 others. By category, its portfolio leans toward Health and bio (11) and Manufacturing and industrial (3). It has co-invested with Eclipse, Songqing Capital and Jifeng Capital, most often Eclipse (3 rounds).

About Decheng Capital

Firm type: Venture capital.
Headquarters: Silicon Valley, US.
Founded: 2012.
Stages: Seed, Series A, Growth.
Sectors: Biotech, Digital Health, Healthtech, Medical Devices.
Leads rounds: No.
Portfolio companies: 86.
Exits: 5.
Rounds led: 4.

What Decheng Capital invests in

Decheng Capital recent investments

How Decheng Capital invests

StageDealsCapital in rounds
Series B+ 8 62%$609M
Series A 4 31%$123M
Seed 1 8%$60M
YearDealsCapital in rounds
2018 2 15%$83M
2020 1 8%$40M
2021 2 15%$157M
2022 1 8%$60M
2025 2 15%$105M
2026 5 38%$347M

Decheng Capital portfolio companies

CompanyRound with Decheng CapitalTotal raisedLatest raise
PPhrontline Biopharma
Health and bio
Series A · $40M · lead$100MNov 12, 2026
Series A
SSleptay
Health and bio
Series A · leadundisclosedSep 28, 2026
Series A
CCellares
Health and bio
Series B+$357MJul 16, 2026
Series B+
PPolares Medical
Health and bio
Series B+ · $50M · lead$115MMar 3, 2026
Series B+
YYolTech Therapeutics
Health and bio
Series B+ · $45M$45MSep 11, 2025
Series B+
MMirvie
Health and bio
Series B+ · $60M · lead$60MMay 17, 2022
Series B+
EEncodia
Health and bio
Series B+ · $75M$75MJun 26, 2024
Series A
VVelosbio
Health and bio
Series A · $58M$58MAug 2, 2026
Series B+
HHaoxinqing
Health and bio
backerundisclosedSep 30, 2026
Series B+
VVintaBio
Health and bio
backer$64MApr 11, 2023
round
AAnHeart Therapeutics
Health and bio
backer$81MDec 14, 2021
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.

Share is of the 13 rounds on Recent Funding that name Decheng Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Decheng Capital, which is a subset of its real portfolio. API: /api/v1/investors/decheng-capital (get a free API key). More: the most active VC firms and new venture capital funds.

Top raises, every week

The week's top funded startups and market insights, in your inbox every Monday.

Unsubscribe anytime · privacy